CUTANEOUS MANIFESTATIONS OF COVID-19

Main Article Content

Maha Rahim Qureshi
Ashok Kumar
Dev Anand
Sanam
FNU Anam
Dr. Lareb Gul
Dr. Ugal Kishore
Dr. Muhammad Ayoob Memon
FNU Partab
Mohsin Ali
Sona Kumari

Keywords

COVID-19, Patients, Manifestation, Lesions

Abstract

Background: Cutaneous manifestations have been increasingly recognized as potential symptoms of COVID-19. Understanding the spectrum of dermatological findings associated with COVID-19 can aid in early recognition, diagnosis, and appropriate management of affected individuals. This structural abstract provides a concise overview of the cutaneous manifestations observed in patients with COVID-19.


Methods: A comprehensive review of published literature and relevant studies was conducted using electronic databases. The search included articles reporting on cutaneous manifestations associated with COVID-19. Data regarding the types of skin lesions, their clinical presentations, and their temporal relationship to COVID-19 were extracted and analyzed.


Results: A total of 100 studies met the inclusion criteria, encompassing a substantial number of COVID-19 patients with cutaneous manifestations. The analysis revealed a diverse range of skin lesions, including erythematous maculopapular rashes, vesicular eruptions, urticaria, livedo reticularis, and acral lesions such as chilblain-like lesions and vesicular-pustular eruptions. Some lesions demonstrated a characteristic distribution pattern, such as the acral distribution observed in COVID-19-associated chilblain-like lesions. The timing of skin manifestations varied, with some occurring before, during, or after the onset of respiratory symptoms.


Conclusion: Cutaneous manifestations are increasingly recognized as potential markers of COVID-19. Dermatological findings can serve as valuable clinical clues in identifying and managing individuals with COVID-19, particularly in the absence of typical respiratory symptoms. Healthcare providers should be aware of the various skin manifestations associated with COVID-19 and consider them in the diagnostic workup of suspected cases. Further research is needed to elucidate the underlying mechanisms and determine the clinical significance of these cutaneous manifestations in COVID-19 patients.

Abstract 460 | pdf Downloads 81

References

1. Freeman EE, McMahon DE, Lipoff JB, et al. Cutaneous manifestations of COVID-19: a preliminary review. J Am Acad Dermatol. 2020;83(3):e211-e212. doi:10.1016/j.jaad.2020.04.018
2. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
3. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-e213. doi:10.1111/jdv.16387
4. Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. Comment on "Cutaneous manifestations in COVID-19: a first perspective" by Recalcati S. J Eur Acad Dermatol Venereol. 2020;34(6):e299-e300. doi:10.1111/jdv.16474
5. Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID-19: report of three cases and a review of literature. J Dermatol Sci. 2020;98(2):75-81. doi:10.1016/j.jdermsci.2020.04.011
6. Conforti C, Dianzani C, Agozzino M, et al. Cutaneous manifestations in confirmed COVID-19 patients: a systematic review. Biology (Basel). 2020;9(12):449. doi:10.3390/biology9120449
7. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285. doi:10.1016/j.jaad.2020.04.044
8. Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. 2020;45(6):746-748. doi:10.1111/ced.14243A
9. Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle). 2021 Feb;10(2):51-80. doi: 10.1089/wound.2020.1309. Epub 2020 Oct 19. PMID: 33035150; PMCID: PMC8020517.
10. Muhammad A, Iftikhar N, Mashhood A, Virdi G, Ud Din H, Akbar A, Ahmad B, Khalid A. Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. Cureus. 2021 Oct 22;13(10):e18973. doi: 10.7759/cureus.18973. PMID: 34820228; PMCID: PMC8606119.
11. Algorithm for the classification of COVID-19 rashes. Ortega-Quijano D, Jimenez-Cauhe J, Selda-Enriquez G, Fernandez-Guarino M, Fernandez-Nieto D. J Am Acad Dermatol. 2020;83:0–4
12. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. Piccolo V, Neri I, Filippeschi C, et al. J Eur Acad Dermatol Venereol. 2020;34:0–3
13. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. Freeman EE, McMahon DE, Lipoff JB, et al. J Am Acad Dermatol. 2020;83:486–492.
14. Hameed S, Elbaaly H, Reid CEL, et al.. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology 2020:202543
15. Panupattanapong S, Brooks EB. New spectrum of COVID-19 manifestations in children: kawasaki-like syndrome and hyperinflammatory response. Cleve Clin J Med 2020. [Epub ahead of print]; DOI: 10.3949/ccjm.87a.ccc039
16. Ghafoor, Rabia, et al. "Cutaneous Manifestations of Coronavirus Disease 2019." Journal of Cosmetic Dermatology, vol. 21, no. 9, 2022, pp. 3667-3672, https://doi.org/10.1111/jocd.15258.
17. Pouletty M, Borocco C, Ouldali N, et al.. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020;79:999–1006
18. Riollano-Cruz M, Akkoyun E, Briceno-Brito E, et al.. Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience. J Med Virol 2020. [Epub ahead of print]; DOI: 10.1002/jmv.26224
19. Garcia-Garcia ML, Calvo Rey C, Pozo Sanchez F, et al.. [Human bocavirus infections in Spanish 0–14 year-old: clinical and epidemiological characteristics of an emerging respiratory virus]. An Pediatr (Barc). 2007;67:212–219

Most read articles by the same author(s)